HOME >> BIOLOGY >> NEWS
Finding rewrites the evolutionary history of the origin of potatoes

MADISON - Humans have cultivated potatoes for millennia, but there has been great controversy about the ubiquitous vegetable's origins. This week, writing in the Proceedings of the National Academies of Sciences, a team led by a USDA potato taxonomist stationed at the University of Wisconsin-Madison has for the first time demonstrated a single origin in southern Peru for the cultivated potato.

The scientists analyzed DNA markers in 261 wild and 98 cultivated potato varieties to assess whether the domestic potato arose from a single wild progenitor or whether it arose multiple times - and the results were clear, says David Spooner, the USDA research scientist who led the study.

"In contrast to all prior hypotheses of multiple origins of the cultivated potato, we have identified a single origin from a broad area of southern Peru," says Spooner, who is also a UW-Madison professor of horticulture. "The multiple-origins theory was based in part on the broad distribution of potatoes from north to south across many different habitats, through morphological resemblance of different wild species to cultivated species, and through other data. Our DNA data, however, shows that in fact all cultivated potatoes can be traced back to a single origin in southern Peru."

The earliest archaeological evidence suggests that potatoes were domesticated from wild relatives by indigenous agriculturalists more than 7,000 years ago, says Spooner. Today, the potato - an international dietary staple - is a major crop in both the United States and in Wisconsin, which is fourth in the nation for potato production.

Potato diseases such as late blight can cause significant economic damage to farmers in America and throughout the world.

"As a taxonomist, my job is to help determine what is a species and to classify those species into related groups," Spooner explains. "Other scientists use these results as a kind of roadmap to guide them in the use of the
'"/>

Contact: David Spooner
dspooner@wisc.edu
608-264-5213
University of Wisconsin-Madison
3-Oct-2005


Page: 1 2

Related biology news :

1. Finding protection from tumor growth in unexpected places
2. Finding the white wine difference
3. Finding an answer to Darwins Dilemma
4. Finding a cure for cancer: The holy grail of science
5. Finding the right mix: A biomaterial blend library
6. Finding paves way for better treatment of autoimmune disease
7. Finding about cellular microtubule rigidity could lead to development of new nano-materials
8. Findings by Einstein scientists reveal possible strategy against obesity, diabetes and infertility
9. Finding of a new molecular marker of resistance to chemotherapy in breast cancer
10. Finding a cellular Neverland: How stem cells stay childlike
11. Finding a virus is not all bad news

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Finding rewrites the evolutionary history the origin potatoes

(Date:10/29/2014)... who lose their hair as a consequence of chemotherapy ... improve the scalp cooling technology that prevents hair loss. ... being pioneered by global scalp cooling manufacturing company, Paxman ... biology department of the University of Huddersfield. , The ... who has a background in the pharmacology of cancer ...
(Date:10/29/2014)... research presented at the Society for Integrative Oncology ... for the first time that it is possible ... readily available nutritional supplement, AHCC. ... Smith, Pharm.D., associate professor in the Department of ... of Texas Health Science Center at Houston (UTHealth) ...
(Date:10/29/2014)... Many factors, both genetic and environmental, have been ... of schizophrenia. Some, such as a family history ... infection with Toxoplasma gondii , a parasite ... are still viewed with skepticism. , A new ... and epidemiology at the University of Pennsylvania,s School ...
Breaking Biology News(10 mins):New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2Penn vet professor investigates parasite-schizophrenia connection 2Penn vet professor investigates parasite-schizophrenia connection 3
(Date:10/27/2014)... and TORONTO , Oct. ... www.generex.com ) (OTCQB: GNBT) today announced two presentations ... triggered by its novel proprietary cancer immunotherapeutic AE37 ... breast cancer patients. The AE37 cancer vaccine is ... Express, Inc. ( www.antigenexpress.com ). The presentations are ...
(Date:10/27/2014)... Orlando, Florida (PRWEB) October 27, 2014 ... aims at reducing and eliminating several types of ... have not been achieved in over 30 years ... of Noah's Light Foundation, proves that one mom's ... was diagnosed just before Halloween trick-or-treating, and it’s ...
(Date:10/27/2014)... October 27, 2014 Investor-Edge has ... (NASDAQ: NBIX ), Insmed Inc. (NASDAQ: ... BCRX ), Dyax Corporation (NASDAQ: DYAX ), ... five companies can be accessed at: http://investor-edge.com/register ... Composite ended at 4,483.72, up 0.69%, the Dow Jones ...
(Date:10/25/2014)... 2014 ViaDerma, Inc ... devoted to bringing new products to market, is ... ViaDerma has developed an innovative, patent-pending dual carrier ... transfer of pharmaceutical active ingredients to penetrate the ... localized therapy. The transdermal delivery method also overcomes ...
Breaking Biology Technology:Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 2Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 3Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 4FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 2FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 2Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 5ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3
Cached News: